Clinical trial
Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3)
NCT02854033 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3)
- Lead sponsor
- University of Southern California
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 2, 2016
- Completion date
- May 28, 2024
- Enrollment
- 1,141 (actual)
- Sites
- 59
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer's disease (ad), mild cognitive impairment (mci)